Skip to main content

Find Clinical Trials

Home
Conditions
HEPATITIS C (HCV)

Clinical trial condition

HEPATITIS C (HCV)

Explore clinical trials studying HEPATITIS C (HCV). Study availability and eligibility vary by location and protocol.

18 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

HEPATITIS C (HCV) trial results

Completed

Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases

NCT07671508

Conditions: Actinomycetales Infections, Agranulocytosis, Bacterial Infections, +25 more
Locations: Not specified

View Trial Details

Completed

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

NCT02493855

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

NCT02716428

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Southern California Research Center Coronado, California, United States

Bach and Godofsky Infectious Diseases Bradenton, Florida, United States

Gastro One Germantown, Tennessee, United States

Auckland Clinical Studies Auckland, New Zealand

View Trial Details

Completed

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

NCT02476617

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

NCT02593162

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Southern California Research Center Coronado, California, United States

View Trial Details

Completed

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

NCT01464827

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Site Reference ID/Investigator# 57583 Birmingham, Alabama, United States

Site Reference ID/Investigator# 55530 Birmingham, Alabama, United States

Site Reference ID/Investigator# 55385 Dothan, Alabama, United States

Site Reference ID/Investigator# 55500 Phoenix, Arizona, United States

View all 97 locations

View Trial Details

Completed

Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554

NCT00651027

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Miami, Florida, United States

View Trial Details

Active, Not Recruiting

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

NCT05657106

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +36 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details